With pharmacy break-ins increasing, this toolkit includes vital resources, solutions and other helpful details. Details included in this toolkit: Robbery and other loss statisticsActions to take after a break-inFrequently Asked Questions with answersBills and Proposed Rules results for “Form-106”Industry resources…
Read More Pharmacy Compliance Toolkit: Break-in/Theft/Loss Recovery Resources & Solutions
With pharmacy break-ins increasing, theft and loss compliance information is even more vital. Background and Statistics With 1 out of every 13 pharmacies having been robbed and 1 out of every 26 pharmacies having been broken into, pharmacies are more…
Since the FDA has released new guidance, do you need to know if your state allows you to order and administer tests for COVID-19, and which tests? Bula now offers 6-month subscriptions to five Clinical Laboratory Improvement Amendments (CLIA) and…
Read More CLIA & POCT FAQ Subscriptions for Pharmacy with COVID-19 Details
Good afternoon, We have recently seen Executive Orders or new subregulations waiving or suspending an existing regulation or statute, if temporarily, during the crisis. These updates are in the Current law Database, but to help you identify these quickly, enclosed is a…
Read More Coronavirus (COVID-19) Legislative Update: A Letter From Our Vice President
Good afternoon, Thank you all for the fantastic feedback we’ve received following our updates. The Bula team worked over the weekend to publish the following sub-regulations, and you’ll find them listed below and in the Current Law Database. Many states…
About Bula Bula is the top subscription-based software solution dedicated to pharmacy compliance that empowers clients by delivering simplified intelligence in an accurate, timely and meaningful manner. It tracks bills, regulations, sub-regulations, rules and policies in all 50 states, D.C.…
It’s hard to ignore the fact that we are in the midst of a nationwide opioid epidemic. In fact, a nationwide public health emergency was declared on October 26, 2017 as a means to combat the opioid abuse crisis.
